Intellectual Property (IP) is a fundamental part of Arecor’s business consolidating its position as an industry leader in innovative formulation technology. Arecor’s patent families, which comprise 22 granted patents, broadly cover the following:
- ArestatTM platform technologies (others are protected by know-how and trade secrets, including a proprietary computational algorithm)
- Blood Factors
- Growth hormones
Arecor works in close coordination with its European and US patent advisors with specialist expertise in formulation patenting, to ensure robust and defensible claims.